GSK gets Boostrix approval for adults over 65

GlaxoSmithKline has gained FDA approval for its tetanus, diphtheria and whooping cough vaccine Boostrix in adults 65 and older. It's the first vaccine that protects older adults from all three diseases with a single shot. With the expanded indication, the vaccine can now be given to people over the age of 10.

"Although many people may have been vaccinated against whooping cough as children, immunity can wear off over time," explained GSK VP of Medical Affairs Leonard Friedland. "Adults, including those age 65 and older, should speak with their healthcare providers to make sure their vaccinations are up to date and to discuss the Centers for Disease Control and Prevention's recommendations for preventing tetanus, diphtheria and pertussis."

Whooping cough cases are on the rise due in part to some parents refusing to get their children vaccinated. Michigan, Ohio, New York and Pennsylvania have all reported a rise in cases of the disease, and California declared a whooping cough epidemic in 2010.

- here's GSK's release
- read more from UPI

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.